Columbia Financial stock hits 52-week high at $18.89

Columbia Financial hit a 52-week high of $18.89, with the stock up 35.6% over the past year and 19.2% year to date. The bank also announced a $597 million merger with Northfield Bancorp that would create the third-largest regional bank headquartered in New Jersey, alongside executive leadership changes. While the stock looks overvalued at a P/E of 33.9, the combination of price strength and strategic M&A supports a constructive near-term read.

Analysis

The near-term trade is less about absolute valuation and more about merger arbitrage and execution credibility. CLBK’s strength is being rewarded because the market is front-running a larger, more liquid regional-bank platform, but that premium can evaporate quickly if integration guidance slips or if regulators push for more concessions. The combined franchise should improve funding durability and cross-sell density, yet those benefits usually show up with a lag; in the first 3-6 months, the stock will trade more on deal spread dynamics and management messaging than on synergies.

A second-order effect is that NFBK holders likely have the cleaner asymmetry here: if the market trusts the exchange ratio and approval path, the buyer’s stock tends to absorb more idiosyncratic execution risk while the target carries a tighter, event-driven profile. For CLBK, the 52-week high can become a self-reinforcing technical level, but that also makes it vulnerable to a fast mean reversion if the deal market weakens or if regional-bank multiples compress on rate volatility. The move is arguably under-diversifying the risk of bank M&A: the biggest threat is not credit quality today, but spread volatility and a repricing of “good enough” growth banks.

The contrarian read is that the premium may already discount too much of the combined company’s value creation. A $18B regional bank with elevated headline optimism can still underperform if the market decides the deal is more defensive scale-building than genuine earnings accretion. In that scenario, upside from here is likely capped in the near term, while downside reopens quickly if the next earnings call reveals integration costs, deposit competition, or slower-than-expected cost saves.

Key Decisions for Investors

• Pair trade: long NFBK / short CLBK into the next 2-8 weeks to capture deal-spread asymmetry and reduce exposure to broad regional-bank beta; thesis breaks if CLBK re-rates higher on explicit EPS accretion or a competing bid.
• If holding CLBK, sell covered calls 1-2 strikes OTM with 1-3 month tenor to monetize the elevated technical premium while capping upside into execution risk.
• For event-driven accounts, buy NFBK on weakness only if the implied spread widens versus historical approval-risk norms; target a 2-4% annualized return with defined downside if regulatory timelines extend.
• Avoid adding outright long CLBK at current levels unless management provides quantified synergy/cost-save targets; risk/reward is skewed to consolidation and post-announcement drift rather than a clean continuation move.